| Yeast Systematic Name | Yeast Symbol | SGDID | Analog Name | Analog Description | EC | Organism | Disease | Structure | Uniprot | Human ID | Human Symbol | HHsearch Probability | HHsearch E_value | HHsearch P_value | HHsearch Score | Flag Disease related | Flag Homo sapiens | Flag Mus musculus | Flag Danio rerio | Flag Drosophila melanogaster | Flag Caenorhabditis elegans | Flag Arabidopsis thaliana | Flag Escherichia coli |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| YNL053W | MSG5 | SGDID:S000004998 | DUSP3 VHR |
Dual specificity protein phosphatase 3 (EC 3.1.3.16) (EC 3.1.3.48) (Dual specificity protein phosphatase VHR) (Vaccinia H1-related phosphatase) (VHR) |
3.1.3.16,3.1.3.48, | Homo sapiens | Cervix Carcinoma,Breast Cancer,Vaccinia,Variola Major,Myoclonic Epilepsy Of Lafora |
3f81_a | P51452 | ENSG00000108861 | DUSP3 | 98.60 | 5.70E-12 | 6.50E-16 | 106.70 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| YNL053W | MSG5 | SGDID:S000004998 | DUSP19 DUSP17 LMWDSP3 SKRP1 |
Dual specificity protein phosphatase 19 (EC 3.1.3.16) (EC 3.1.3.48) (Dual specificity phosphatase TS-DSP1) (Low molecular weight dual specificity phosphatase 3) (LMW-DSP3) (Protein phosphatase SKRP1) (Stress-activated protein kinase pathway-regulating phosphatase 1) (SAPK pathway-regulating phosphatase 1) |
3.1.3.16,3.1.3.48, | Homo sapiens | 3s4e_a | Q8WTR2 | ENSG00000162999 | DUSP19 | 98.40 | 4.00E-11 | 4.70E-15 | 96.00 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | |
| YNL053W | MSG5 | SGDID:S000004998 | DUSP7 PYST2 |
Dual specificity protein phosphatase 7 (EC 3.1.3.16) (EC 3.1.3.48) (Dual specificity protein phosphatase PYST2) |
3.1.3.16,3.1.3.48, | Homo sapiens | Pulmonary Systemic Sclerosis,Variola Major |
4y2e_b | Q16829 | ENSG00000164086 | DUSP7 | 98.60 | 4.80E-12 | 5.70E-16 | 101.50 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| YNL053W | MSG5 | SGDID:S000004998 | DUSP23 LDP3 VHZ |
Dual specificity protein phosphatase 23 (EC 3.1.3.16) (EC 3.1.3.48) (Low molecular mass dual specificity phosphatase 3) (LDP-3) (VH1-like phosphatase Z) |
3.1.3.16,3.1.3.48, | Homo sapiens | 4erc_b | Q9BVJ7 | ENSG00000158716 | DUSP23 | 98.50 | 1.30E-11 | 1.60E-15 | 100.20 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | |
| YNL053W | MSG5 | SGDID:S000004998 | H1L |
Dual specificity protein phosphatase H1 (EC 3.1.3.-) (EC 3.1.3.48) (Late protein H1) |
3.1.3.48 | Vaccinia virus | 2rf6_a | P07239 | 98.40 | 7.50E-11 | 8.50E-15 | 99.50 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| YNL053W | MSG5 | SGDID:S000004998 | Dusp28 |
Dual specificity phosphatase 28 (EC 3.1.3.16) (EC 3.1.3.48) |
3.1.3.16,3.1.3.48, | Mus musculus | 2hcm_a | Q8BTR5 | 98.60 | 4.80E-12 | 5.70E-16 | 103.40 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | |||
| YNL053W | MSG5 | SGDID:S000004998 | DUSP10 MKP5 |
Dual specificity protein phosphatase 10 (EC 3.1.3.16) (EC 3.1.3.48) (Mitogen-activated protein kinase phosphatase 5) (MAP kinase phosphatase 5) (MKP-5) |
3.1.3.16,3.1.3.48, | Homo sapiens | Shwartzman Phenomenon |
1zzw_a | Q9Y6W6 | ENSG00000143507 | DUSP10 | 98.60 | 6.30E-12 | 7.60E-16 | 100.50 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| YNL053W | MSG5 | SGDID:S000004998 | CDKN3 CDI1 CIP2 KAP |
Cyclin-dependent kinase inhibitor 3 (EC 3.1.3.16) (EC 3.1.3.48) (CDK2-associated dual-specificity phosphatase) (Cyclin-dependent kinase interactor 1) (Cyclin-dependent kinase-interacting protein 2) (Kinase-associated phosphatase) |
3.1.3.16,3.1.3.48, | Homo sapiens | Endometrial Cancer,Bladder Lateral Wall Cancer,Cowden Syndrome,Endometrial Hyperplasia,Ovary Sarcoma,Retinal Cancer,Epicardium Cancer,Mandibular Cancer,Cystic Fibrosis,Colon Sarcoma,Cervix Carcinoma,Ovarian Cancer,Breast Cancer,Glioblastoma,Colorectal Cancer,Hepatocellular Carcinoma,Cerebral Cavernous Malformations,Centronuclear Myopathy,Prostate Cancer,Type 2 Diabetes Mellitus,Fragile X Syndrome,Lymphoma, Non-Hodgkin, Familial,Beckwith-Wiedemann Syndrome,Fanconi Renotubular Syndrome 1,Brugada Syndrome 4,Acute Promyelocytic Leukemia,Juvenile Myelomonocytic Leukemia,Ataxia-Telangiectasia,Melanoma, Cutaneous Malignant 1 |
1fpz_e | Q16667 | ENSG00000100526 | CDKN3 | 98.40 | 5.20E-11 | 5.90E-15 | 103.50 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| YNL053W | MSG5 | SGDID:S000004998 | DUSP9 MKP4 |
Dual specificity protein phosphatase 9 (EC 3.1.3.16) (EC 3.1.3.48) (Mitogen-activated protein kinase phosphatase 4) (MAP kinase phosphatase 4) (MKP-4) |
3.1.3.16,3.1.3.48, | Homo sapiens | 3lj8_a | Q99956 | ENSG00000130829 | DUSP9 | 98.30 | 9.10E-11 | 1.10E-14 | 93.40 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | |
| YNL053W | MSG5 | SGDID:S000004998 | EPM2A |
Laforin (EC 3.1.3.-) (EC 3.1.3.16) (EC 3.1.3.48) (Glucan phosphatase) (Glycogen phosphatase) (Lafora PTPase) (LAFPTPase) |
3.1.3.16,3.1.3.48, | Homo sapiens | Progressive Myoclonus Epilepsy,Chromosome 1q21.1 Duplication Syndrome,Epilepsy,Myoclonus Epilepsy,Endocervical Carcinoma,Progressive Myoclonus Epilepsy 10,Progressive Myoclonus Epilepsy 6,Dementia,Progressive Myoclonus Epilepsy, Lafora Type,Early Myoclonic Encephalopathy,Myoclonus,Benign Epilepsy With Centrotemporal Spikes,Unverricht-Lundborg Syndrome,Dentatorubral-Pallidoluysian Atrophy,Glycogen Storage Disease Iv,Ovary Transitional Cell Carcinoma,Neonatal Period Electroclinical Syndrome,Epilepsy, Myoclonic Juvenile,Myoclonic Epilepsy Of Lafora,Myoclonic Epilepsy Of Unverricht And Lundborg |
4r30_c | O95278 | ENSG00000112425 | EPM2A | 98.40 | 5.70E-11 | 6.50E-15 | 100.70 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| YNL053W | MSG5 | SGDID:S000004998 | 01orf_00051 |
01orf_00051 |
3.1.3.- | Orf virus | 5ncr_a | Q6TW43 | 98.30 | 1.20E-10 | 1.30E-14 | 99.90 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| YNL053W | MSG5 | SGDID:S000004998 | DUSP13 DUSP13B TMDP |
Dual specificity protein phosphatase 13 isoform B (DUSP13B) (EC 3.1.3.16) (EC 3.1.3.48) (Dual specificity phosphatase SKRP4) (Testis- and skeletal-muscle-specific DSP) |
3.1.3.16,3.1.3.48, | Homo sapiens | Cowden Syndrome,Cardiomyopathy, Dilated, 1a,Juvenile Polyposis Syndrome,Ring Dermoid Of Cornea,Ruvalcaba Syndrome,Emery-Dreifuss Muscular Dystrophy 2, Autosomal Dominant,Myoclonic Epilepsy Of Lafora |
2gwo_c | Q9UII6 | ENSG00000079393 | DUSP13 | 98.80 | 9.20E-13 | 1.00E-16 | 114.90 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| YNL053W | MSG5 | SGDID:S000004998 | DUSP4 MKP2 VH2 |
Dual specificity protein phosphatase 4 (EC 3.1.3.16) (EC 3.1.3.48) (Dual specificity protein phosphatase hVH2) (Mitogen-activated protein kinase phosphatase 2) (MAP kinase phosphatase 2) (MKP-2) |
3.1.3.16,3.1.3.48, | Homo sapiens | Ogden Syndrome |
3ezz_b | Q13115 | ENSG00000120875 | DUSP4 | 98.40 | 4.30E-11 | 5.20E-15 | 94.60 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| YNL053W | MSG5 | SGDID:S000004998 | orf98 ptp-2 |
orf98 ptp-2 |
Cydia pomonella | 6i28_a | Q91EV7 | 98.60 | 7.70E-12 | 8.70E-16 | 105.00 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
| YNL053W | MSG5 | SGDID:S000004998 | DUSP29 DUPD1 DUSP27 |
Dual specificity phosphatase 29 (Dual specificity phosphatase 27) (Dual specificity phosphatase DUPD1) (EC 3.1.3.16) (EC 3.1.3.48) |
3.1.3.16,3.1.3.48, | Homo sapiens | Clubfoot,Familial Clubfoot With Or Without Associated Lower Limb Anomalies,Kat6b-Related Multiple Congenital Anomalies Syndrome,Cryptorchidism, Unilateral Or Bilateral,Kat6b Disorders,Cervix Carcinoma,Blepharophimosis,Lin-Gettig Syndrome,Ohdo Syndrome, Say-Barber-Biesecker-Young-Simpson Variant,Alacrima, Achalasia, And Mental Retardation Syndrome,Clubfoot, Congenital, With Or Without Deficiency Of Long Bones And/Or Mirror-Image Polydactyly,Disease Of Mental Health,Ohdo Syndrome, Sbbys Variant,Variola Major,Genitopatellar Syndrome,Hypertelorism,Ohdo Syndrome |
2y96_a | Q68J44 | ENSG00000188716 | DUPD1 | 98.90 | 1.10E-13 | 1.20E-17 | 123.60 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| YNL053W | MSG5 | SGDID:S000004998 | tpbA PA3885 |
tpbA PA3885 |
Pseudomonas aeruginosa | 4r0s_b | Q9HXC7 | 98.30 | 1.20E-10 | 1.30E-14 | 103.50 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
| YNL053W | MSG5 | SGDID:S000004998 | CTHT_0021070 |
CTHT_0021070 |
3.1.3.48 | Chaetomium thermophilum | 5m43_a | G0S3H6 | 98.70 | 2.10E-12 | 2.20E-16 | 117.40 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| YNL053W | MSG5 | SGDID:S000004998 | SIW14 OCA3 YNL032W N2746 |
Inositol phosphatase SIW14 (EC 3.6.1.52) (5-PP-InsP phosphatase) (Inositol pyrophosphate phosphatase SIW14) (Oxidant-induced cell-cycle arrest protein 3) (Synthetic interaction with WHI2 protein 14) |
3.6.1.52 | Saccharomyces cerevisiae | 6byf_b | P53965 | 98.30 | 1.10E-10 | 1.30E-14 | 97.80 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| YNL053W | MSG5 | SGDID:S000004998 | STYX |
Serine/threonine/tyrosine-interacting protein (Inactive tyrosine-protein phosphatase STYX) (Phosphoserine/threonine/tyrosine interaction protein) |
Homo sapiens | Type 1 Diabetes Mellitus |
2r0b_a | Q8WUJ0 | ENSG00000198252 | STYX | 98.60 | 7.80E-12 | 9.30E-16 | 101.10 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | |
| YNL053W | MSG5 | SGDID:S000004998 | DUSP28 |
Dual specificity phosphatase 28 (EC 3.1.3.16) (EC 3.1.3.48) |
3.1.3.16,3.1.3.48, | Homo sapiens | 5y15_a | Q4G0W2 | ENSG00000188542 | DUSP28 | 98.50 | 2.80E-11 | 3.00E-15 | 106.00 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | |
| YNL053W | MSG5 | SGDID:S000004998 | DUSP16 KIAA1700 MKP7 |
Dual specificity protein phosphatase 16 (EC 3.1.3.16) (EC 3.1.3.48) (Mitogen-activated protein kinase phosphatase 7) (MAP kinase phosphatase 7) (MKP-7) |
3.1.3.16,3.1.3.48, | Homo sapiens | Obstructive Hydrocephalus |
4yr8_d | Q9BY84 | ENSG00000111266 | DUSP16 | 98.50 | 1.30E-11 | 1.40E-15 | 103.80 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| YNL053W | MSG5 | SGDID:S000004998 | SDP1 YIL113W |
Dual-specificity protein phosphatase SDP1 (EC 3.1.3.48) (Stress-inducible MAPK phosphatase) |
3.1.3.48 | Saccharomyces cerevisiae | 2j16_a | P40479 | 98.90 | 2.20E-13 | 2.40E-17 | 117.20 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| YNL053W | MSG5 | SGDID:S000004998 | DUSP18 LMWDSP20 |
Dual specificity protein phosphatase 18 (EC 3.1.3.16) (EC 3.1.3.48) (Low molecular weight dual specificity phosphatase 20) (LMW-DSP20) |
3.1.3.16,3.1.3.48, | Homo sapiens | 2esb_a | Q8NEJ0 | ENSG00000167065 | DUSP18 | 98.60 | 1.20E-11 | 1.30E-15 | 106.90 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | |
| YNL053W | MSG5 | SGDID:S000004998 | DSP1 PTP135 At1g05000 T7A14.14 |
Tyrosine-protein phosphatase DSP1 (EC 3.1.3.48) (Protein PLANT AND FUNGI ATYPICAL DUAL-SPECIFICITY PHOSPHATASE 1) (AtPFA-DSP1) (Tyrosine-protein phosphatase At1g05000) |
3.1.3.48 | Arabidopsis thaliana | 1xri_b | Q9ZVN4 | 98.30 | 1.30E-10 | 1.50E-14 | 95.30 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | |||
| YNL053W | MSG5 | SGDID:S000004998 | DUSP5 VH3 |
Dual specificity protein phosphatase 5 (EC 3.1.3.16) (EC 3.1.3.48) (Dual specificity protein phosphatase hVH3) |
3.1.3.16,3.1.3.48, | Homo sapiens | Diamond-Blackfan Anemia 4,Schuurs-Hoeijmakers Syndrome,Syphilitic Meningitis,Lymphoma, Mucosa-Associated Lymphoid Type,Autosomal Dominant Non-Syndromic Intellectual Disability |
2g6z_a | Q16690 | ENSG00000138166 | DUSP5 | 98.80 | 4.20E-13 | 4.50E-17 | 119.70 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| YNL053W | MSG5 | SGDID:S000004998 | DUSP26 DUSP24 LDP4 MKP8 NATA1 SKRP3 |
Dual specificity protein phosphatase 26 (EC 3.1.3.16) (EC 3.1.3.48) (Dual specificity phosphatase SKRP3) (Low-molecular-mass dual-specificity phosphatase 4) (DSP-4) (LDP-4) (Mitogen-activated protein kinase phosphatase 8) (MAP kinase phosphatase 8) (MKP-8) (Novel amplified gene in thyroid anaplastic cancer) |
3.1.3.16,3.1.3.48, | Homo sapiens | Dopamine Beta-Hydroxylase Deficiency,Neuroblastoma |
2e0t_a | Q9BV47 | ENSG00000133878 | DUSP26 | 98.40 | 4.70E-11 | 5.60E-15 | 95.40 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| YNL053W | MSG5 | SGDID:S000004998 | RPL39 RPL46 SPB2 YJL189W J0360 |
60S ribosomal protein L39 (L46) (Large ribosomal subunit protein eL39) (YL40) |
Saccharomyces cerevisiae | 6n8o_y | P04650 | 98.70 | 1.50E-12 | 1.50E-16 | 128.30 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
| YNL053W | MSG5 | SGDID:S000004998 | SSH2 KIAA1725 SSH2L |
Protein phosphatase Slingshot homolog 2 (EC 3.1.3.16) (EC 3.1.3.48) (SSH-like protein 2) (SSH-2L) (hSSH-2L) |
3.1.3.16,3.1.3.48, | Homo sapiens | Familial Renal Oncocytoma |
2nt2_a | Q76I76 | ENSG00000141298 | SSH2 | 98.60 | 8.10E-12 | 9.80E-16 | 99.00 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| YNL053W | MSG5 | SGDID:S000004998 | DUSP12 |
Dual specificity protein phosphatase 12 (EC 3.1.3.16) (EC 3.1.3.48) (Dual specificity tyrosine phosphatase YVH1) |
3.1.3.16,3.1.3.48, | Homo sapiens | 4ki9_a | Q9UNI6 | ENSG00000081721 | DUSP12 | 98.40 | 7.00E-11 | 8.10E-15 | 97.40 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | |
| YNL053W | MSG5 | SGDID:S000004998 | DUSP8 C11orf81 VH5 |
Dual specificity protein phosphatase 8 (EC 3.1.3.16) (EC 3.1.3.48) (Dual specificity protein phosphatase hVH-5) |
3.1.3.16,3.1.3.48, | Homo sapiens | 4jmk_a | Q13202 | ENSG00000184545 | DUSP8 | 98.60 | 6.80E-12 | 8.00E-16 | 101.60 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | |
| YNL053W | MSG5 | SGDID:S000004998 | SSO2453 |
SSO2453 |
Saccharolobus solfataricus | 2i6i_a | Q97VZ7 | 98.40 | 8.10E-11 | 9.40E-15 | 97.00 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
| YNL053W | MSG5 | SGDID:S000004998 | DUSP13 BEDP DUSP13A MDSP |
Dual specificity protein phosphatase 13 isoform A (DUSP13A) (EC 3.1.3.16) (EC 3.1.3.48) (Branching-enzyme interacting DSP) (Muscle-restricted DSP) (MDSP) |
3.1.3.16,3.1.3.48, | Homo sapiens | Cowden Syndrome,Cardiomyopathy, Dilated, 1a,Juvenile Polyposis Syndrome,Ring Dermoid Of Cornea,Ruvalcaba Syndrome,Emery-Dreifuss Muscular Dystrophy 2, Autosomal Dominant,Myoclonic Epilepsy Of Lafora |
5xjv_b | Q6B8I1 | ENSG00000079393 | DUSP13 | 98.50 | 1.70E-11 | 1.90E-15 | 104.70 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| YNL053W | MSG5 | SGDID:S000004998 | DUSP22 JSP1 LMWDSP2 MKPX |
Dual specificity protein phosphatase 22 (EC 3.1.3.16) (EC 3.1.3.48) (JNK-stimulatory phosphatase-1) (JSP-1) (Low molecular weight dual specificity phosphatase 2) (LMW-DSP2) (Mitogen-activated protein kinase phosphatase x) (MAP kinase phosphatase x) (MKP-x) |
3.1.3.16,3.1.3.48, | Homo sapiens | Breast Implant-Associated Anaplastic Large Cell Lymphoma,Duane Retraction Syndrome,Anterior Segment Dysgenesis 3,Sezary'S Disease,Alk-Negative Anaplastic Large Cell Lymphoma,Variola Major,Mature T-Cell And Nk-Cell Lymphoma,Anaplastic Large Cell Lymphoma,Peripheral T-Cell Lymphoma |
4woh_a | Q9NRW4 | ENSG00000112679 | DUSP22 | 98.50 | 1.70E-11 | 2.00E-15 | 102.30 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| YNL053W | MSG5 | SGDID:S000004998 | DUSP14 MKP6 |
Dual specificity protein phosphatase 14 (EC 3.1.3.16) (EC 3.1.3.48) (MKP-1-like protein tyrosine phosphatase) (MKP-L) (Mitogen-activated protein kinase phosphatase 6) (MAP kinase phosphatase 6) (MKP-6) |
3.1.3.16,3.1.3.48, | Homo sapiens | Frontometaphyseal Dysplasia,Variola Major |
2wgp_a | O95147 | ENSG00000276023 | DUSP14 | 98.40 | 6.00E-11 | 6.60E-15 | 102.40 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| YNL053W | MSG5 | SGDID:S000004998 | YVH1 YIR026C |
Tyrosine-protein phosphatase YVH1 (PTPase YVH1) (EC 3.1.3.48) |
3.1.3.48 | Saccharomyces cerevisiae | 6rzz_s | Q02256 | 98.70 | 1.50E-12 | 1.50E-16 | 128.30 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| YNL053W | MSG5 | SGDID:S000004998 | Tk-ptp TK0241 |
Tk-ptp TK0241 |
Thermococcus kodakarensis | 5z59_a | Q8X270 | 98.70 | 2.00E-12 | 2.40E-16 | 103.90 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
| YNL053W | MSG5 | SGDID:S000004998 | Ptpmt1 Plip |
Phosphatidylglycerophosphatase and protein-tyrosine phosphatase 1 (EC 3.1.3.27) (PTEN-like phosphatase) (Phosphoinositide lipid phosphatase) (Protein-tyrosine phosphatase mitochondrial 1) (EC 3.1.3.16) (EC 3.1.3.48) |
3.1.3.16,3.1.3.27,3.1.3.48 | Mus musculus | 3rgo_a | Q66GT5 | 98.60 | 4.80E-12 | 5.60E-16 | 103.40 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | |||
| YNL053W | MSG5 | SGDID:S000004998 | DUSP15 C20orf57 VHY |
Dual specificity protein phosphatase 15 (EC 3.1.3.16) (EC 3.1.3.48) (VH1-related member Y) (Vaccinia virus VH1-related dual-specific protein phosphatase Y) |
3.1.3.16,3.1.3.48, | Homo sapiens | Nanophthalmos |
1yz4_a | Q9H1R2 | ENSG00000149599 | DUSP15 | 98.70 | 3.30E-12 | 3.90E-16 | 104.60 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| YNL053W | MSG5 | SGDID:S000004998 | EHI_044170 |
EHI_044170 |
3.1.3.- | Entamoeba histolytica | 3emu_a | D0VX03 | 98.60 | 7.60E-12 | 8.80E-16 | 103.50 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |